Search - tctmd.com

Displaying 21 - 40 of 50

Sort: Relevancy | Date

News Conference News AHA 2020

OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

Shelley Wood

November 14, 2020

News Features

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Shelley Wood

July 20, 2020

News Daily News

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

Shelley Wood

March 04, 2020

News Daily News

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

Shelley Wood

February 19, 2020

News Conference News AHA 2019

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Michael O'Riordan

November 14, 2019

News Daily News

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Caitlin E. Cox

July 15, 2019

News Conference News EuroPCR 2019

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

Shelley Wood

May 16, 2019

News Industry News

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

May 02, 2019

News Daily News

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Michael O'Riordan

November 23, 2018

News Conference News AHA 2018

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

Michael O'Riordan

November 10, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for September 2018

Shelley Wood

October 02, 2018

News Conference News ESC 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

Shelley Wood

September 14, 2018

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for August 2018

Caitlin E. Cox

September 04, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Shelley Wood

April 18, 2018

News Daily News

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

L.A. McKeown

December 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

REVASCTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

News Conference News TCT 2017

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Todd Neale

October 31, 2017

News Daily News

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

Todd Neale

October 23, 2017

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Shelley Wood

March 10, 2017

Advertisement

OCT and MRI Find an MI Cause in 85% of Women With MINOCA: HARP

COVID-19’s Enduring Impact on the Heart? Some Clues and Predictions

Type 2 MI Linked to More CV Deaths, Even in Younger Patients

PCI for Preventing Death in Unstable vs Stable CAD: New Data, More Soul-searching

More Ischemia on Stress Echo Equals Greater Angina Benefit With PCI: ORBITA

Silent MI Often Precedes Sudden Cardiac Death, Finnish Data Confirm

Off to EuroPCR 2019? Expect Mitral and Tricuspid Updates, Thin-Strut Stent Surprises, and ‘Strong’ Statements

FDA Approves Initiation of STEMI DTU Pivotal Randomized Controlled Trial

Angina Without Obstructive Stenosis: No Longer a ‘Black Box’ Mystery, Say Experts

Methotrexate, an Anti-inflammatory, Fails to Lower Risk of Cardiovascular Events: CIRT

TCTMD’s Top 10 Most Popular Stories for September 2018

My Takeaways From ESC 2018: Good or Bad, the Luxury of New Data Begets Cries for More

TCTMD’s Top 10 Most Popular Stories for August 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Silent MI Often Precedes Acute MI, Portends Worse Patient Outcomes

Secondary Prevention Improves Survival After STEMI Discharge but Is Widely Underprescribed

Live From Denver: TCT 2017, Day Three

REVASC: CTO PCI Does Not Improve LV Function but Seems to Provide Symptom Relief

Any Stable Troponin T Level Detectable by a High-Sensitivity Assay Signals Higher Death Risk

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content